Lipoic acid downmodulates CD4 from human T lymphocytes by dissociation of p56(Lck)

Biochemical and Biophysical Research Communications
Gail H MarracciDennis N Bourdette

Abstract

Lipoic acid is an antioxidant that suppresses and treats a model of multiple sclerosis, experimental autoimmune encephalomyelitis. We now demonstrate that treatment of human PBMC and T cell lines with LA downmodulated CD4 expression in a concentration-dependent manner. LA treatment of Con A stimulated PBMC specifically removed CD4 from the T-cell surface, but not CD3. Epitope masking by LA was excluded by using monoclonal antibodies targeting different domains of CD4. Incubation on ice inhibited CD4 removal following LA treatment, suggesting that endocytosis was involved in its downmodulation. LA is in a unique category of compounds that induce CD4 downmodulation by various mechanisms (e.g., gangliosides). We hypothesized that LA might induce dissociation of p56(Lck) from CD4, thus leading to its downmodulation. Immunoblot analyses demonstrated reduced co-precipitation of p56(Lck) from Jurkat T-cells following LA treatment and precipitation of CD4. This unique immunomodulatory effect of LA warrants further investigation.

References

Jan 1, 1992·Annual Review of Immunology·R MartinD E McFarlin
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B P SleckmanS J Burakoff
Sep 1, 1991·Immunopharmacology·W J MorrisonA A Vandenbark
Mar 1, 1991·The Journal of Experimental Medicine·A Pelchen-MatthewsM Marsh
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D ScholsE De Clercq
Aug 25, 1995·The Journal of Biological Chemistry·L PondP A Peterson
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·S SalghettiJ Skowronski
Feb 1, 1995·Scandinavian Journal of Immunology·M SoriceM R Torrisi
Oct 29, 1993·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A N BarclayG Lange
Sep 1, 1994·European Journal of Immunology·D R KohT W Mak
Jan 1, 1997·Free Radical Biology & Medicine·L PackerK Wessel
Sep 1, 1997·General Pharmacology·G P BiewengaA Bast
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
Jul 21, 1998·The Journal of Biological Chemistry·M HuseS C Harrison
Nov 26, 1998·The Journal of Biological Chemistry·R S LinH F Lodish
Jul 17, 1999·Multiple Sclerosis : Clinical and Laboratory Research·S Schmidt
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·J StrongN Killeen
Oct 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Q WangN Killeen
Dec 18, 2002·The Biochemical Journal·Tomas Mustelin, Kjetil Taskén
Jan 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Roben FragosoYong-Jiu Jin
Sep 23, 2003·Science·Peter W KimMichael J Eck
Dec 11, 2003·Multiple Sclerosis : Clinical and Laboratory Research·Shunya NakaneNoritoshi Shibuya
May 12, 2004·Current Medicinal Chemistry·A R SmithT M Hagen
Sep 25, 2004·Journal of Neuroscience Research·Gail H MarracciDennis N Bourdette

❮ Previous
Next ❯

Citations

May 15, 2009·Journal of Virology·Nadine LaguetteStéphane Basmaciogullari
Oct 12, 2010·PloS One·Sonemany SalinthoneDaniel W Carr
Jun 14, 2016·Expert Opinion on Drug Delivery·Giovanni MonastraVittorio Unfer
Sep 3, 2008·Immunopharmacology and Immunotoxicology·Abbas Mirshafiey, Monireh Mohsenzadegan
Apr 25, 2019·BioMed Research International·Wei LiuSheng-Guang Li
Aug 12, 2009·Biochimica Et Biophysica Acta·Kate Petersen ShayTory M Hagen
Nov 3, 2010·The Journal of Nutritional Biochemistry·Sonemany SalinthoneDaniel W Carr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.